Literature DB >> 6501136

Effect of antibiotic use on the incidence of cephalosporin resistance in two Australian hospitals.

R A Benn, R J Kemp.   

Abstract

The incidence of resistance of Gram-negative bacteria to three generations of cephalosporins was surveyed in two large hospitals with widely differing rates of cephalosporin usage. Overall resistance (MIC greater than 5 mg/l) of Enterobacteriaceae to cefotaxime in the hospital using large amounts of cephalosporins was 4% compared with 0.7% in the other. Enterobacter species accounted for most resistant isolates and resistant Enterobacter cloacae replaced sensitive strains in four patients given cefotaxime in 1983. The distribution of species colonizing intensive care areas was similar in both hospitals with cephalosporin-resistant Pseudomonas aeruginosa and Acinetobacter calcoaceticus predominating.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6501136     DOI: 10.1093/jac/14.suppl_b.71

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  4 in total

1.  Epidemiology of intestinal colonization by members of the family Enterobacteriaceae resistant to cefotaxime in a hematology-oncology unit.

Authors:  M H Prevot; A Andremont; H Sancho-Garnier; C Tancrede
Journal:  Antimicrob Agents Chemother       Date:  1986-12       Impact factor: 5.191

Review 2.  Clinical importance of inducible beta-lactamases in gram-negative bacteria.

Authors:  C C Sanders; W E Sanders
Journal:  Eur J Clin Microbiol       Date:  1987-08       Impact factor: 3.267

Review 3.  Drug utilisation review (DUR) of the third generation cephalosporins. Focus on ceftriaxone, ceftazidime and cefotaxime.

Authors:  A Adu; C L Armour
Journal:  Drugs       Date:  1995-09       Impact factor: 9.546

4.  Activity of cefepime against ceftazidime- and cefotaxime-resistant gram-negative bacteria and its relationship to beta-lactamase levels.

Authors:  J Fung-Tomc; T J Dougherty; F J DeOrio; V Simich-Jacobson; R E Kessler
Journal:  Antimicrob Agents Chemother       Date:  1989-04       Impact factor: 5.191

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.